Sign in
Taking peopleNo phase

Role of Pavlovian Mechanisms for Control Over Substance Use

Key facts

Who runs it
Technische Universität Dresden
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
200 people, planned
Started
5 Aug 2024
Expected to end
30 Jun 2027
Type of study
Observational, 4 groups
Treatments tested
  • fMRI imaging (BOLD)
  • sMRI (structure)
  • Pavlovian-to-instrumental transfer (PIT) paradigm
  • Basic psychological assessment (interview)
  • Basic psychological assessment (questionnaires)
  • Neuropsychological tests
Record updated
22 November 2024

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Men and women between 18-65 years of age,
  • AUD, and/or SUD subjects only: meet 4 or more criteria for DSM-5 alcohol-related and/or substance-related (cannabis, amphetamine, methamphetamine or cocaine disorder (not requiring withdrawal as assessed by an independent psychiatrist),
  • Currently using alcohol without a desire for abstinence
  • Ability to consent to the study and complete the questionnaires
  • Sufficient language(German) and motor skills for using PC
  • existing health insurance

Who cannot take part

  • Ingestion of medications known to interact with the dopamine system in the 10-day period prior to study participation or less than 4 half-lives after last ingestion (rapid urine test); A detailed list of permitted medication can be added upon request
  • MR contraindications (e.g., pacemakers, metallic or electronic implants, metallic splinters, surgical staples)
  • Acute alcohol, substance (cannabis, or methamphetamine, amphetamine, cocaine) intoxication at assessement day verified by breath alcohol tests and drug intoxication verified by rapid urine test
  • Lifetime diagnosis of DSM-5 bipolar disorder or schizophrenia or schizophrenia spectrum disorder (if induced by drugs, it should happen more than a month ago)
  • Current threshold DSM-5 diagnosis of major depressive disorder, or presence of suicidal intention
  • History of traumatic brain injury or severe neurological disease (such as Dementia, Parkinson's disease, multiple sclerosis, Epilepsy, Meningitis, Stroke)
  • High risk (≤ 26) ASSIST scores in other substances other than alcohol, amphetamine, methamphetamine, cannabis, cocaine, tobacco
  • Pregnancy or breastfeeding,
  • Color vision deficiency
  • sensorineural hearing loss of 30 dB or greater,
  • Tinnitus and

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

During the first funding period (1st FP), the investigators developed a novel full Pavlovian-to-instrumental transfer (PIT) task that allows assessing both, general and specific PIT to investigate whether specific PIT differs between alcohol use disorder (AUD) and control subjects. Preliminary analyses of the full transfer task indicate that AUD participants exhibit a stronger specific PIT effect compared to controls. Based on these findings, the investigators want to compare specific and general PIT effects in patients with moderate to severe substance use disorders (alcohol, cannabis, methamphetamine, amphetamine and cocaine) to healthy controls on the behavioral and neural level (fMRI).

The 4 groups in the trial

  • Alcohol use disorder (AUD)

    Participants with alcohol use disorder (moderate to severe if no withdrawal symptoms) and no other substance use disorder (SUD)

    Treatment: fMRI imaging (BOLD), sMRI (structure), Pavlovian-to-instrumental transfer (PIT) paradigm, Basic psychological assessment (interview), Basic psychological assessment (questionnaires), and Neuropsychological tests

  • Alcohol use disorder (AUD) and Substance use disorder (SUD)

    Participants with Alcohol use disorder (AUD) and comorbid Substance use disorder (SUD) (moderate to severe cases without withdrawal symptoms) including: Participants with alcohol use disorder (AUD) and/or cannabis use disorder and/or methamphetamine use disorder and/or amphetamine use disorder and/or cocaine use disorder.

    Treatment: fMRI imaging (BOLD), sMRI (structure), Pavlovian-to-instrumental transfer (PIT) paradigm, Basic psychological assessment (interview), Basic psychological assessment (questionnaires), and Neuropsychological tests

  • Non-AUD Substance use disorder (SUD)

    Participants with substance use disorder (moderate to severe cases without withdrawal symptoms) without alcohol use disorder (AUD) including: Participants with methamphetamine use disorder and/or cannabis use disorder and/or amphetamine use disorder and/or cocaine use disorder

    Treatment: fMRI imaging (BOLD), sMRI (structure), Pavlovian-to-instrumental transfer (PIT) paradigm, Basic psychological assessment (interview), Basic psychological assessment (questionnaires), and Neuropsychological tests

  • Control group

    Healthy participants without AUD or SUD

    Treatment: fMRI imaging (BOLD), sMRI (structure), Pavlovian-to-instrumental transfer (PIT) paradigm, Basic psychological assessment (interview), Basic psychological assessment (questionnaires), and Neuropsychological tests

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
SFB TRR 265: Losing and Regaining Control Over Drug Intake Work Package 1 of Project B03: General and Specific Pavlovian-to-Instrumental Transfer Effects in a Range of Substance Use Disorders
Fit questions
Built from NCT06701487, who can take part
Record updated
22 November 2024